Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Nov 21, 2014; 20(43): 16029-16036
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16029
Published online Nov 21, 2014. doi: 10.3748/wjg.v20.i43.16029
Figure 1 Hepatic metabolism of proton pump inhibitors (except rabeprazole) (A) and metabolic pathways of proton pump inhibitors and their cytochrome P450 (CYP) isoforms involved (B).
-
Citation: Kuo CH, Lu CY, Shih HY, Liu CJ, Wu MC, Hu HM, Hsu WH, Yu FJ, Wu DC, Kuo FC. CYP2C19 polymorphism influences
Helicobacter pylori eradication. World J Gastroenterol 2014; 20(43): 16029-16036 - URL: https://www.wjgnet.com/1007-9327/full/v20/i43/16029.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i43.16029